Correlation between human vascular smooth muscle cell proliferation and protein kinase Cα-expression: Effect of d-α-tocopherol

Biochemistry and Molecular Biology International

Volumn 40, Issue 4, 1996, Pages 699-707

  Marilley, Dominique ^a   Mosieniak, Grazina ^a   Boscoboinik, Daniel ^a   Azzi, Angelo ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

d tocopherol; Primary human cell culture; Protein kinase C isoforms; Vascular smooth muscle cell

Indexed keywords

ALPHA TOCOPHEROL; ISOENZYME; PROTEIN KINASE C;

AORTA MEDIA; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; VASCULAR SMOOTH MUSCLE;

EID: 0029948301     PISSN: 10399712     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216549600201303     Document Type: Article

References (25)

1. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809.
2. Raines, E. W. and R. Ross. 1993. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br. Heart J. 69:S30-S37.
3. Bornfeldt, K. E., E. W. Raines, T. Nakano, L. M. Graves, E. G. Krebs, and R. Ross. 1994. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J. Clin. Invest. 93:1266-1274.
4. Schlessinger, J. and A. Ullrich. 1992. Growth factor signaling by receptor tyrosine kinases. Neuron 9:383-391.
5. Muller, R., D. Mumberg, and F. C. Lucibello. 1993. Signals and genes in the control of cell-cycle progression. Biochim. Biophys. Acta 1155:151-179.
6. Azzi, A., D. Boscoboinik, and C. Hensey. 1992. The protein kinase C family. Eur. J. Biochem. 208:547-557.
7. Jaken, S. 1996. Protein kinase C isozymes and substrates. Curr. Opin. Cell Biol. 8:168-173.
8. Adamo, S., C. Caporale, S. Aguanno, J. Lazdins, A. Faggioni, L. Belli, E. Cortesi, C. Nervi, R. Gastaldi, and M. Molinaro. 1986. Proliferating and quiescent cells exhibit different subcellular distribution of protein kinase C activity. FEBS Lett. 195:352-356.
9. Hirst, S. J., B. L. J. Webb, M. A. Giembycz, P. J. Barnes, and C. H. C. Twort. 1995. Inhibition of fetal calf serum-stimulated proliferation of rabbit cultured tracheal smooth muscle cells by selective inhibitors of protein kinase C and protein tyrosine kinase. Am. J. Respir. Cell Mol. Biol. 12:149-161.
10. Newby, A. C., J. W. Assender, M. A. Evans, K. Lim, M. R. Bennett, and G. I. Evan. 1994. Transduction pathways for growth stimulatory and inhibitory actions of vasoactive agents. Exp. Nephrol. 2:94-100.
11. Kariya, K., Y. Fukumoto, T. Tsuda, Y. Kawahara, H. Fukuzaki, T. Yamamoto, and Y. Takai. 1987. Inhibition of DNA synthesis by phorbol esters through protein kinase C in cultured rabbit aortic smooth muscle cells. FEBS Lett. 217:69-73.
12. Kariya, K. I., Y. Kawahara, T. Tsuda, H. Fukuzaki, and Y. Takai. 1987. Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cells. Atherosclerosis 63:251-255.
13. Newby, A. C., K. Lim, M. A. Evans, N. P. Brindle, and R. F. Booth. 1995. Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C. Br. J. Pharmacol. 114:1652-1656.
14. Assender, J. W., E. Kontny, and B. B. Fredholm. 1994. Expression of protein kinase C isoforms in smooth muscle cells in various states of differentiation. FEBS Lett. 342:76-80.
15. Rimm, E. B., M. J. Stampfer, A. Ascherio, E. Giovannucci, G. A. Colditz, and W. C. Willett. 1993. Vitamin E consumption and the risk of coronary heart disease in men (see comments). N. Engl. J. Med. 328:1450-1456.
16. Stampfer, M. J., C. H. Hennekens, J. E. Manson, G. A. Colditz, B. Rosner, and W. C. Willett. 1993. Vitamin E consumption and the risk of coronary disease in women (see comments). N. Engl. J. Med. 328:1444-1449.
17. Stephens, N. G., A. Parsons, P. M. Schofield, F. Kelly, K. Cheeseman, M. J. Mitchinson, and M. J. Brown. 1996. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781-786.
18. Verlangieri, A. J. and M. J. Bush. 1992. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J. Am. Coll. Nutr. 11:131-138.
19. Özer, N. K., P. Palozza, D. Boscoboinik, and A. Azzi. 1993. d-alpha-Tocopherol inhibits low density lipoprotein induced proliferation and protein kinase C activity in vascular smooth muscle cells. FEES Lett. 322:307-310.
20. Chatelain, E., D. O. Boscoboinik, G. M. Bartoli, V. E. Kagan, F. K. Gey, L. Packer, and A. Azzi. 1993. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim. Biophys. Acta 1176:83-89.
21. Boscoboinik, D., N. K. Özer, U. Moser, and A. Azzi. 1995. Tocopherols and 6-hydroxy-chroman-2-carbonitrile derivatives inhibit vascular smooth muscle cell proliferation by a nonantioxidant mechanism. Arch. Biochem. Biophys. 318:241-246.
22. Boscoboinik, D. O., E. Chatelain, G. M. Bartoli, B. Stäuble, and A. Azzi. 1994. Inhibition of protein kinase C activity and vascular smooth muscle cell growth by d-alpha-tocopherol. Biochim. Biophys. Acta 1224:418-426.
23. Tasinato, A., D. Boscoboinik, G. M. Bartoli, P. Maroni, and A. Azzi. 1995. d-α-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad. Sci. USA 92:12190-12194.
24. Alexander, D. R., J. D. Graves, S. C. Lucas, D. A. Cantrell, and M. J. Crumpton. 1990. A method for measuring protein kinase C activity in permeabilized T lymphocytes by using peptide substrates. Evidence for multiple pathways of kinase activation. Biochem. J. 268:303-308.
25. Sirikci, Ö., N. K. Özer, and A. Azzi. 1996. Dietary cholesterol-induced changes of protein kinase C and the effect of vitamin E in rabbit aorta smooth muscle cells. Atherosclerosis in press